Evidence map›Paper›PMID 40963557›Full record

ArticleParenting, science and practice2024

Development of a Clinical Decision-Making Framework to Address Parental Substance Use and Child Safety.

Davida M Schiff, Galya Walt, Martha Kane, Melissa Maitland, Gina Liu, Sarah E Wakeman, Jessica R Gray

Abstract read
In one paragraph

Article in Parenting, science and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Davida M SchiffDivisions of General Academic Pediatrics and Newborn Medicine, Mass General for Children, Boston, MA.
Galya WaltDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Martha KaneProgram on Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA, United States.
Melissa MaitlandProgram on Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA, United States.
Gina LiuHarvard Medical School, Boston, MA, United States.
Sarah E WakemanProgram on Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA, United States.
Jessica R GrayProgram on Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA, United States.

Funding

Improving Treatment Engagement and Adherence to Optimize Outcomes for Opioid-Exposed Mother-Infant DyadsK23DA048169 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI SCHIFF, DAVIDA · 2019 to 2023
$998k
NIDA NIH HHS K23 DA048169
6 · The paper itself

Abstract

Objective: Clinicians caring for families impacted by substance use disorder often feel uncomfortable assessing for child protective concerns in the setting of non-prescribed parental substance use. This leads to a lack of standardization of care, where some clinicians choose to not ask any questions about the care of children for fear of receiving information that will leave them in an uncomfortable position as a mandated reporter, while others may reflexively report any identification of substance use to child protective services. The primary aim of this descriptive manuscript is to present a framework developed by a multidisciplinary team in a medical setting to address concerns about a recurrence of parental substance use. Design: We will highlight the development, implementation, and evolution of a clinical decision-making framework designed to help standardize clinicians' discussions around whether substance use could be affecting a parent's ability to safely care for their children. Discussion: Five main assessment areas will be discussed, including: 1). Safety of the child while substance use is occurring; 2). Safety of parental use patterns; 3). Parental treatment engagement; 4). Willingness to escalate treatment services; and 5). Stability of the home environment. We will present a clinical scenario to highlight how the framework is used as an aid to determine action planning with respect to immediate safety concerns, treatment escalation, and opportunities to maximize recovery supports. We discuss the challenges we've experienced and opportunities that arise in attempting to incorporate the principles of harm reduction within the context of assessments of child safety and well-being.

Indexed as

child safetyclinical decision makingfamily well-beingharm reductionparental substance use

Identifiers

PMID40963557
PMCPMC12440385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.